









Mercado
/
Acciones
/
nasdaq-mdt
/

Medtronic PLC

MDT

101.000USD

+0.210+0.21%

Cierre 01/29, 16:00（ET）Cotizaciones retrasadas 15 min

129.48BCap. mercado

27.18P/E TTM



Medtronic PLC

101.000

+0.210+0.21%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Medtronic PLC Compañía

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Información de Medtronic PLC



Símbolo de cotizaciónMDT

Nombre de la empresaMedtronic PLC

Fecha de salida a bolsaNov 21, 1977

Director ejecutivoMartha (Geoffrey S)

Número de empleados95000

Tipo de seguridadOrdinary Share

Fin del año fiscalNov 21

DirecciónBuilding Two Parkmore Business Park West

CiudadDUBLIN

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísIreland

Código postalH91 4K49

Teléfono1135314381700

Sitio Webhttps://www.medtronic.com/

Símbolo de cotizaciónMDT

Fecha de salida a bolsaNov 21, 1977

Director ejecutivoMartha (Geoffrey S)

Ejecutivos de Medtronic PLC



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.90M

-1564.00%

Mr. Brett A. Wall

Executive Vice President, President - Neuroscience Portfolio

548.17K

-439.00%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-3541.00%

Mr. Kendall J. (Ken) Powell

Independent Director

48.84K

+890.00%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Americas

48.26K

-1371.00%

Mr. Craig Arnold

Lead Independent Director

40.24K

+73.00%

Mr. Scott C. Donnelly

Independent Director

21.71K

+192.00%

Dr. Elizabeth G. (Betsy) Nabel, M.D.

Independent Director

17.64K

+72.00%

Mr. Kevin E. Lofton

Independent Director

8.19K

+72.00%

Mr. Thierry Jean Louis Pieton

Chief Financial Officer, Executive Vice President

7.39K

-32060.00%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.90M

-1564.00%

Mr. Brett A. Wall

Executive Vice President, President - Neuroscience Portfolio

548.17K

-439.00%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-3541.00%

Mr. Kendall J. (Ken) Powell

Independent Director

48.84K

+890.00%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Americas

48.26K

-1371.00%

Mr. Craig Arnold

Lead Independent Director

40.24K

+73.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2026Q2

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Cardiac Rhythm & Heart Failure

1.82B

20.37%

Surgical & Endoscopy

1.68B

18.74%

Cranial & Spinal Technologies

1.30B

14.50%

Structural Heart & Aortic

956.00M

10.67%

Specialty Therapies

744.00M

8.30%

Otro

2.46B

27.43%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

4.52B

50.40%

Rest of World

4.41B

49.21%

Ireland

35.00M

0.39%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Cardiac Rhythm & Heart Failure

1.82B

20.37%

Surgical & Endoscopy

1.68B

18.74%

Cranial & Spinal Technologies

1.30B

14.50%

Structural Heart & Aortic

956.00M

10.67%

Specialty Therapies

744.00M

8.30%

Otro

2.46B

27.43%

Estadísticas de accionistas

Actualizado: lun., 17 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

10.01%

BlackRock Institutional Trust Company, N.A.

5.18%

State Street Investment Management (US)

4.72%

JP Morgan Asset Management

2.92%

Capital Research Global Investors

2.39%

Otro

74.78%

Accionistas

Proporción

The Vanguard Group, Inc.

10.01%

BlackRock Institutional Trust Company, N.A.

5.18%

State Street Investment Management (US)

4.72%

JP Morgan Asset Management

2.92%

Capital Research Global Investors

2.39%

Otro

74.78%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

46.88%

Investment Advisor/Hedge Fund

29.43%

Research Firm

4.36%

Pension Fund

2.40%

Bank and Trust

2.16%

Hedge Fund

1.41%

Sovereign Wealth Fund

1.37%

Insurance Company

0.38%

Individual Investor

0.28%

Otro

11.33%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

3674

1.13B

88.21%

-17.18M

2025Q3

3723

1.13B

88.20%

-2.77M

2025Q2

3762

1.12B

87.12%

-18.03M

2025Q1

3818

1.13B

88.15%

+2.18M

2024Q4

3768

1.12B

87.17%

+3.13M

2024Q3

3708

1.10B

85.63%

-24.55M

2024Q2

3725

1.11B

86.25%

-54.16M

2024Q1

3789

1.14B

85.95%

-7.87M

2023Q4

3780

1.13B

85.36%

-20.57M

2023Q3

3761

1.14B

85.37%

-14.93M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

130.95M

10.21%

+4.49M

+3.55%

Nov 28, 2025

BlackRock Institutional Trust Company, N.A.

66.42M

5.18%

-1.42M

-2.10%

Sep 30, 2025

State Street Investment Management (US)

60.46M

4.72%

+625.99K

+1.05%

Sep 30, 2025

JP Morgan Asset Management

37.48M

2.92%

+11.18M

+42.48%

Sep 30, 2025

Capital Research Global Investors

30.69M

2.39%

-5.67M

-15.58%

Sep 30, 2025

Geode Capital Management, L.L.C.

27.65M

2.16%

-579.44K

-2.05%

Sep 30, 2025

MFS Investment Management

19.44M

1.52%

+75.05K

+0.39%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

16.44M

1.28%

+1.87M

+12.83%

Jun 30, 2025

Managed Account Advisors LLC

14.98M

1.17%

+1.21M

+8.79%

Sep 30, 2025

BlackRock Financial Management, Inc.

14.32M

1.12%

-1.30M

-8.33%

Sep 30, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

Absolute Select Value ETF

4.89%

iShares U.S. Medical Devices ETF

4.4%

iShares Health Innovation Active ETF

4.26%

Cullen Enhanced Equity Income ETF

4.24%

USCF Dividend Income Fund

3.59%

JPMorgan Healthcare Leaders ETF

3.22%

Madison Dividend Value ETF

3.08%

Tema Heart & Health ETF

2.98%

Global X Aging Population ETF

2.98%

WisdomTree US AI Enhanced Value Fund

2.86%

Absolute Select Value ETF

Proporción4.89%

iShares U.S. Medical Devices ETF

Proporción4.4%

iShares Health Innovation Active ETF

Proporción4.26%

Cullen Enhanced Equity Income ETF

Proporción4.24%

USCF Dividend Income Fund

Proporción3.59%

JPMorgan Healthcare Leaders ETF

Proporción3.22%

Madison Dividend Value ETF

Proporción3.08%

Tema Heart & Health ETF

Proporción2.98%

Global X Aging Population ETF

Proporción2.98%

WisdomTree US AI Enhanced Value Fund

Proporción2.86%

Dividendos



Un total de 17.37B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Dec 04, 2025

MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 16, 2026 going ex on Dec 26, 2025 with reinvestment option

Dec 26, 2025

Jan 16, 2026

Dec 26, 2025

Aug 14, 2025

MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Oct 17, 2025 going ex on Sep 26, 2025 with reinvestment option

Sep 26, 2025

Oct 17, 2025

Sep 26, 2025

May 21, 2025

MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 11, 2025 going ex on Jun 27, 2025 with reinvestment option

Jun 27, 2025

Jul 11, 2025

Jun 27, 2025

Mar 06, 2025

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option

Mar 28, 2025

Apr 11, 2025

Mar 28, 2025

Dec 05, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option

Dec 27, 2024

Jan 10, 2025

Dec 27, 2024

Aug 16, 2024

MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option

Sep 27, 2024

Oct 11, 2024

Sep 27, 2024

May 23, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option

Jun 28, 2024

Jul 12, 2024

Jun 28, 2024

Mar 07, 2024

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option

Mar 22, 2024

Apr 12, 2024

Mar 21, 2024

Dec 07, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023

Dec 20, 2023

Jan 12, 2024

Dec 19, 2023

Aug 17, 2023

MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option

Sep 22, 2023

Oct 13, 2023

Sep 21, 2023

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

